Background. Chronic heart failure (CHF) is one of the key problems of the domestic healthcare system. E-health capabilities can be used to improve the quality of medical care and reduce the frequency of hospitalizations and mortality.
Aim. To study the effect of telemedicine monitoring on mortality, the number of repeated hospitalizations and the clinical and functional status of patients with CHF.
Material and methods. A prospective, controlled, randomized study was conducted on the basis of the Central City Hospital №20 in Yekaterinburg from December 2020 to December 2022. Patients with a confirmed diagnosis of CHF were randomized by the envelope method into 3 groups: group 1 a group of telephone control (DN) (n=58), group 2 - a group of remote control with usage medical platform Medsenger (n=52), group 3 a group of standard control (n=103). All patients underwent an examination, a study of the level of NT-proBNP. Echocardiography when included in the study and time intervals of 3,6,12 months for evaluation, the onset of primary and secondary endpoints was evaluated at reference points. Statistical processing was performed using Stata14 and jamovi programs.
Results. The study involved 213 people, 3 groups were comparable in terms of basic demographic and clinical characteristics. The advantage of remote control (group 1+group 2) over face-to-face observation in reducing cardiovascular mortality was revealed after 3 months (OR 2.73, CI 95% (1.1; 7.39), p=0.042) and after 12 months (OR 2.1, CI 95% (1.1; 3.7), p=0.027) and events of the combined primary endpoint (OR 2.1, CI 95% (1.1; 5.6), p = 0.015) after 12 months.
When using the Medsenger platform, the ejection fraction increased from 47% initially to 55% after 12 months (p=0.004). The level of NT-proBNP decreased after 3 months from 817 (331;1480) pg/ml to 582 (208;896) pg/ml (p0.001), after 12 months to 233 (128;638) pg/ml (p0.001).
Conclusion. The development of remote monitoring protocols can be a good alternative to the traditional face-to-face monitoring of patients with CHF, leading to an improvement in clinical and functional health indicators.